133 related articles for article (PubMed ID: 17684930)
21. Differentiated thyroid cancer in children: diagnosis and management.
Dinauer CA; Breuer C; Rivkees SA
Curr Opin Oncol; 2008 Jan; 20(1):59-65. PubMed ID: 18043257
[TBL] [Abstract][Full Text] [Related]
22. [Medullary thyroid carcinoma and some of its particularities].
Sidibé el H
Sante; 2007; 17(1):51-5. PubMed ID: 17897902
[TBL] [Abstract][Full Text] [Related]
23. P53 is an independent prognostic factor for survival in thyroid cancer.
Bachmann K; Pawliska D; Kaifi J; Schurr P; Zörb J; Mann O; Kahl HJ; Izbicki JR; Strate T
Anticancer Res; 2007; 27(6B):3993-7. PubMed ID: 18225561
[TBL] [Abstract][Full Text] [Related]
24. Expression of the melanoma-associated antigen is associated with progression of human thyroid cancer.
Cheng S; Liu W; Mercado M; Ezzat S; Asa SL
Endocr Relat Cancer; 2009 Jun; 16(2):455-66. PubMed ID: 19261683
[TBL] [Abstract][Full Text] [Related]
25. Lessons from a review of thyroglobulin assays in the management of thyroid cancer.
Wong J; Lu Z; Doery J; Fuller P
Intern Med J; 2008 Jun; 38(6):441-4. PubMed ID: 18613899
[TBL] [Abstract][Full Text] [Related]
26. [Tumor markers for thyroid malignant disease].
Tamura K
Nihon Rinsho; 2011 Mar; 69 Suppl 2():298-303. PubMed ID: 21830558
[No Abstract] [Full Text] [Related]
27. [Oncogens and tumor makers in thyroid cancer].
Hashimoto T; Matsubara F; Mizukami Y; Michigishi T; Miyazaki I
Rinsho Byori; 1989 Feb; 37(2):122-30. PubMed ID: 2733178
[No Abstract] [Full Text] [Related]
28. HBME-1 and CK19 are highly discriminatory in the cytological diagnosis of papillary thyroid carcinoma.
Nga ME; Lim GS; Soh CH; Kumarasinghe MP
Diagn Cytopathol; 2008 Aug; 36(8):550-6. PubMed ID: 18618720
[TBL] [Abstract][Full Text] [Related]
29. Recent developments in predicting thyroid malignancy.
Stang MT; Carty SE
Curr Opin Oncol; 2009 Jan; 21(1):11-7. PubMed ID: 19125013
[TBL] [Abstract][Full Text] [Related]
30. Measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer.
Spencer CA; Lopresti JS
Nat Clin Pract Endocrinol Metab; 2008 Apr; 4(4):223-33. PubMed ID: 18268520
[TBL] [Abstract][Full Text] [Related]
31. [Clinical, morphologic and immunohistochemical factors of prognosis in papillary cancer of the thyroid].
Shkurko OA
Vopr Onkol; 2008; 54(1):19-24. PubMed ID: 18416052
[No Abstract] [Full Text] [Related]
32. Cell cycle regulators show diagnostic and prognostic utility for differentiated thyroid cancer.
Melck A; Masoudi H; Griffith OL; Rajput A; Wilkins G; Bugis S; Jones SJ; Wiseman SM
Ann Surg Oncol; 2007 Dec; 14(12):3403-11. PubMed ID: 17882495
[TBL] [Abstract][Full Text] [Related]
33. [Thyroid papillary cancer using TPO staining].
Nygaard B; Frisch T; Kiss K
Ugeskr Laeger; 2008 Apr; 170(18):1571. PubMed ID: 18454932
[TBL] [Abstract][Full Text] [Related]
34. [Tumor markers in the early diagnosis of thyroid neoplasms].
Re M; Pepe M; Orlando G; Sorcini G; Clemenzia G; Canova R; Falcone M; Cancrini A; Gallo G; Russo G
Minerva Med; 1989 Apr; 80(4):341-3. PubMed ID: 2725934
[TBL] [Abstract][Full Text] [Related]
35. [Galectin-3 in diagnosis of thyroid cancer].
Semenov DIu; Pozharisskiĭ KM; Boriskova ME; Pankova PA; Mukhina MS; Feshchenko NS
Vopr Onkol; 2008; 54(3):321-3. PubMed ID: 18652236
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of peripheral thyrotropin receptor mRNA in follow-up of differentiated thyroid cancer.
Milas M; Barbosa GF; Mitchell J; Berber E; Siperstein A; Gupta M
Ann Surg Oncol; 2009 Feb; 16(2):473-80. PubMed ID: 19015922
[TBL] [Abstract][Full Text] [Related]
37. Is thyroglobulin the stronger indicator for progressive disease than the other conventional factors in same age patient groups with differentiated thyroid cancer?
Aras G; Gültekin SS; Küçük NO; Genç Y
Nucl Med Commun; 2007 Dec; 28(12):907-13. PubMed ID: 18090216
[TBL] [Abstract][Full Text] [Related]
38. Methylation status of genes in papillary thyroid carcinoma.
Smith JA; Fan CY; Zou C; Bodenner D; Kokoska MS
Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1006-11. PubMed ID: 17938324
[TBL] [Abstract][Full Text] [Related]
39. Clinical implication of F-18 FDG PET/CT for differentiated thyroid cancer in patients with negative diagnostic iodine-123 scan and elevated thyroglobulin.
Kim SJ; Lee TH; Kim IJ; Kim YK
Eur J Radiol; 2009 Apr; 70(1):17-24. PubMed ID: 18207685
[TBL] [Abstract][Full Text] [Related]
40. Medullary thyroid carcinoma and biomarkers: past, present and future.
van Veelen W; de Groot JW; Acton DS; Hofstra RM; Höppener JW; Links TP; Lips CJ
J Intern Med; 2009 Jul; 266(1):126-40. PubMed ID: 19522831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
